Vidarbha’ Under-23 cricketer Akshay Dullarwar has been suspended by Board of Control For Cricket in India (BCCI) for doping violation.
According to BCCI Dullarwar had inadvertently ingested a prohibited substance for treatment of an infection. Dullarwar had provided a urine sample as part of the BCCI’s anti-doping testing programme during the Men’s Under-23 One-day match on March 10, 2019 in Hyderabad. His sample was subsequently tested and found to contain Desacetyl Deflazacort, a metabolite of Deflazacort, which is a Glucocorticoid that is prohibited In-Competition in the WADA Prohibited List of Substances.
On June 26, Dullarwar was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge. Dullarwar responded to the charge by admitting the ADRV but asserting that it was inadvertent, being caused by his ingestion of the medication that had been prescribed for him by his doctor.
The eight-month period of Ineligibility will be deemed to have started to run on 10th March 2019, so that it will end at midnight on November 09, 2019.
Dullarwar may return to train with team or to use the facilities of any club or other member organisation of the BCCI after midnight on September 9, 2019.
Get the latest Nagpur sports news and breaking news and headlines from cricket, football, badminton, cycling, etc. Stay updated with Nagpur’s very own 24*7 online news portal, THE LIVE NAGPUR.